Home> Trial Details

Information Clinical trials have complex eligibility criteria.
Always talk to your clinician about you’re interest in participating in a trial.Learn why

Optimise reading forHealth Professionals Patients

RecruitingLast updated:21 May 2021

FeRIC (Fe dEficiency in ColoRectal Cancer): This phase IV trial is trying to determine if giving an iron infusion to iron-deficient colorectal cancer patients who are anaemic versus not anaemic will improve their physical fitness for planned surgeryAn iron infusion with Ferric Carboxymaltose as a technique of improving physiological reserve in iron deficient patients undergoing surgery for colorectal cancer: a randomized control trial

Clinical summary Eligibilty Participating hospital Support

Clinical summary

Summary

Eligible patients will be randomly (by chance) allocated to receive an infusion enriched with 1000mg iron (Ferric Carboxymaltose) OR a saline solution of similar appearance. All participants will receive maximum of 250mls of 0.9% saline solution with or without iron (depending on group) over a 15 minute period. All patients will be monitored for 30 minutes following completion of the infusion. No further blood tests will be required on the day of the infusion.

Age

People 18+

Phase

Trial Acronym

FeRIC (Fe dEficiency in ColoRectal Cancer)

More information

Trial Identifiers

Use the hyperlinks, where available to access additional clinical trial information.

ACTRN12616001219471

Commercial Sponsor

Peter MacCallum Cancer Centre

Scientific Title

An iron infusion with Ferric Carboxymaltose as a technique of improving physiological reserve in iron deficient patients undergoing surgery for colorectal cancer: a randomized control trial

Share with email